Cargando…

Clinical course and visual outcome in patients with diabetes mellitus and uveitis

PURPOSE: We report the clinical course and visual outcome of patients with diabetes mellitus (DM) who subsequently developed uveitis from any cause. METHODS: Longitudinal, retrospective case note review. RESULTS: A total of 36 patients (M/F: 18/18, 58 eyes) were included, Of the 36 patients, 35 had...

Descripción completa

Detalles Bibliográficos
Autores principales: Oswal, Kadambari S, Sivaraj, Ramesh R, Murray, Philip I, Stavrou, Panagiota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651352/
https://www.ncbi.nlm.nih.gov/pubmed/23628425
http://dx.doi.org/10.1186/1756-0500-6-167
_version_ 1782269211721072640
author Oswal, Kadambari S
Sivaraj, Ramesh R
Murray, Philip I
Stavrou, Panagiota
author_facet Oswal, Kadambari S
Sivaraj, Ramesh R
Murray, Philip I
Stavrou, Panagiota
author_sort Oswal, Kadambari S
collection PubMed
description PURPOSE: We report the clinical course and visual outcome of patients with diabetes mellitus (DM) who subsequently developed uveitis from any cause. METHODS: Longitudinal, retrospective case note review. RESULTS: A total of 36 patients (M/F: 18/18, 58 eyes) were included, Of the 36 patients, 35 had Type 2 DM and one had Type 1 DM. Mean age of onset of DM was 49 years and uveitis 55 years. The uveitis was bilateral in 22 (61%) patients. There were 19 patients with anterior uveitis, 12 with panuveitis and 5 with intermediate uveitis. Mean follow up was 4.4 years (range 1-18). Mean number of uveitis recurrences was 3 (range 1-7). Causes of vision of 6/18 or worse appeared related to the uveitis in 9 eyes and diabetes in 4 eyes. Cataract occurred in 22 eyes, glaucoma in 17 eyes, and cystoid macular oedema in 10 eyes. Diabetic retinopathy was detected in 38 (65.5%) eyes (29 non-proliferative including 6 with clinically significant macular oedema, and 9 proliferative). Progression of diabetic retinopathy to proliferative stage occurred in 7 eyes of 4 patients over a mean duration of 4.4 years. In 10 patients with active uveitis the mean HbA1c was 80 mmol/mol [9.5%], (range 49-137 [6.6-14.7]), and 67 mmol/mol [8.3%] (range 46-105 [6.4-11.8]) when the uveitis was quiescent, p = 0.01. Better glycaemic control was required in 10 patients during episodes of uveitis. CONCLUSIONS: Patients with DM who develop uveitis may have a high complication rate, reduced vision and poor glycaemic control. Checking blood glucose during episodes of uveitis is important.
format Online
Article
Text
id pubmed-3651352
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36513522013-05-11 Clinical course and visual outcome in patients with diabetes mellitus and uveitis Oswal, Kadambari S Sivaraj, Ramesh R Murray, Philip I Stavrou, Panagiota BMC Res Notes Short Report PURPOSE: We report the clinical course and visual outcome of patients with diabetes mellitus (DM) who subsequently developed uveitis from any cause. METHODS: Longitudinal, retrospective case note review. RESULTS: A total of 36 patients (M/F: 18/18, 58 eyes) were included, Of the 36 patients, 35 had Type 2 DM and one had Type 1 DM. Mean age of onset of DM was 49 years and uveitis 55 years. The uveitis was bilateral in 22 (61%) patients. There were 19 patients with anterior uveitis, 12 with panuveitis and 5 with intermediate uveitis. Mean follow up was 4.4 years (range 1-18). Mean number of uveitis recurrences was 3 (range 1-7). Causes of vision of 6/18 or worse appeared related to the uveitis in 9 eyes and diabetes in 4 eyes. Cataract occurred in 22 eyes, glaucoma in 17 eyes, and cystoid macular oedema in 10 eyes. Diabetic retinopathy was detected in 38 (65.5%) eyes (29 non-proliferative including 6 with clinically significant macular oedema, and 9 proliferative). Progression of diabetic retinopathy to proliferative stage occurred in 7 eyes of 4 patients over a mean duration of 4.4 years. In 10 patients with active uveitis the mean HbA1c was 80 mmol/mol [9.5%], (range 49-137 [6.6-14.7]), and 67 mmol/mol [8.3%] (range 46-105 [6.4-11.8]) when the uveitis was quiescent, p = 0.01. Better glycaemic control was required in 10 patients during episodes of uveitis. CONCLUSIONS: Patients with DM who develop uveitis may have a high complication rate, reduced vision and poor glycaemic control. Checking blood glucose during episodes of uveitis is important. BioMed Central 2013-04-29 /pmc/articles/PMC3651352/ /pubmed/23628425 http://dx.doi.org/10.1186/1756-0500-6-167 Text en Copyright © 2013 Oswal et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Oswal, Kadambari S
Sivaraj, Ramesh R
Murray, Philip I
Stavrou, Panagiota
Clinical course and visual outcome in patients with diabetes mellitus and uveitis
title Clinical course and visual outcome in patients with diabetes mellitus and uveitis
title_full Clinical course and visual outcome in patients with diabetes mellitus and uveitis
title_fullStr Clinical course and visual outcome in patients with diabetes mellitus and uveitis
title_full_unstemmed Clinical course and visual outcome in patients with diabetes mellitus and uveitis
title_short Clinical course and visual outcome in patients with diabetes mellitus and uveitis
title_sort clinical course and visual outcome in patients with diabetes mellitus and uveitis
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651352/
https://www.ncbi.nlm.nih.gov/pubmed/23628425
http://dx.doi.org/10.1186/1756-0500-6-167
work_keys_str_mv AT oswalkadambaris clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis
AT sivarajrameshr clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis
AT murrayphilipi clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis
AT stavroupanagiota clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis